Skip to main content
Fig. 3 | BMC Women's Health

Fig. 3

From: Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma

Fig. 3

(A) Distribution of the 32 DEGs at the gene set level. (B) Genes differentially expressed between the PR and PS involved in two or all the PI3K, MAPK, and Cell Cycle-Apoptosis pathways. NGF, nerve growth factor; AKT3, v-akt murine thymoma viral oncogene homolog 3; CCND2, cyclin D2; PDGFRA, platelet-derived growth factor receptor, alpha polypeptide; CCND1, cyclin D1; CCND3, cyclin D3; FGF9, fibroblast growth factor 9; FGF11, fibroblast growth factor 11

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us